View ValuationPaushak 将来の成長Future 基準チェック /06現在、 Paushakの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長18.2%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報お知らせ • Jun 02Paushak Limited Announces Temporary Suspension of Manufacturing OperationsPaushak Limited informing about the temporary suspension of company manufacturing operations due to restriction in supply of oxygen for industrial purposes. Company informed that the company has resumed its manufacturing operations as supply of industrial oxygen has been re-stored by the supplier, upon receipt of requisite approvals for the purpose.すべての更新を表示Recent updatesお知らせ • 7hPaushak Limited, Annual General Meeting, Jul 30, 2026Paushak Limited, Annual General Meeting, Jul 30, 2026, at 17:00 Indian Standard Time.お知らせ • Apr 28Paushak Limited to Report Q4, 2026 Results on May 05, 2026Paushak Limited announced that they will report Q4, 2026 results on May 05, 2026Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹423, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 54% over the past three years.New Risk • Mar 23New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹9.20b (US$98.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (17% net profit margin). Market cap is less than US$100m (₹9.20b market cap, or US$98.4m).New Risk • Jan 28New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 18% Last year net profit margin: 27% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.2% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (18% net profit margin).お知らせ • Jan 19Paushak Limited to Report Q3, 2026 Results on Jan 27, 2026Paushak Limited announced that they will report Q3, 2026 results on Jan 27, 2026Valuation Update With 7 Day Price Move • Nov 14Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹597, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 44% over the past three years.Reported Earnings • Nov 08Second quarter 2026 earnings released: EPS: ₹27.94 (vs ₹5.76 in 2Q 2025)Second quarter 2026 results: EPS: ₹27.94. Revenue: ₹598.3m (up 4.4% from 2Q 2025). Net income: ₹86.1m (down 39% from 2Q 2025). Profit margin: 14% (down from 25% in 2Q 2025). The decrease in margin was driven by higher expenses.お知らせ • Oct 31Paushak Limited to Report Q2, 2026 Results on Nov 07, 2025Paushak Limited announced that they will report Q2, 2026 results on Nov 07, 2025Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹960, the stock trades at a trailing P/E ratio of 46.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 13% over the past three years.New Risk • Oct 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 25% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (25% average weekly change). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₹2.96b market cap, or US$33.3m).Reported Earnings • Aug 01First quarter 2026 earnings released: EPS: ₹39.04 (vs ₹33.44 in 1Q 2025)First quarter 2026 results: EPS: ₹39.04 (up from ₹33.44 in 1Q 2025). Revenue: ₹577.7m (up 11% from 1Q 2025). Net income: ₹120.3m (up 17% from 1Q 2025). Profit margin: 21% (in line with 1Q 2025). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.お知らせ • Jul 23Paushak Limited to Report Q1, 2026 Results on Jul 31, 2025Paushak Limited announced that they will report Q1, 2026 results on Jul 31, 2025Upcoming Dividend • Jul 17Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 24 July 2025. Payment date: 30 August 2025. Payout ratio is a comfortable 12% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.7%).Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹5,656, the stock trades at a trailing P/E ratio of 35.3x. Average trailing P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 39% over the past three years.Reported Earnings • Jul 03Full year 2025 earnings released: EPS: ₹160 (vs ₹176 in FY 2024)Full year 2025 results: EPS: ₹160 (down from ₹176 in FY 2024). Revenue: ₹2.11b (up 2.3% from FY 2024). Net income: ₹493.8m (down 9.2% from FY 2024). Profit margin: 23% (down from 26% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.Declared Dividend • Jun 30Dividend of ₹20.00 announcedDividend of ₹20.00 is the same as last year. Ex-date: 24th July 2025 Payment date: 30th August 2025 Dividend yield will be 0.4%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (12% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 7.2% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jun 30Paushak Limited, Annual General Meeting, Jul 31, 2025Paushak Limited, Annual General Meeting, Jul 31, 2025, at 17:00 Indian Standard Time.Reported Earnings • May 03Full year 2025 earnings released: EPS: ₹160 (vs ₹176 in FY 2024)Full year 2025 results: EPS: ₹160 (down from ₹176 in FY 2024). Revenue: ₹2.25b (up 9.2% from FY 2024). Net income: ₹493.8m (down 9.1% from FY 2024). Profit margin: 22% (down from 26% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.お知らせ • May 01Paushak Limited Recommends Dividend for the Year Ended March 31, 2025Paushak Limited at its board meeting held on May 1, 2025, recommended a dividend of INR 20 (200%) per Equity Share having face value of INR 10 each for the year ended March 31, 2025, subject To Approve the Shareholders at the upcoming Annual General Meeting (AGM).お知らせ • Apr 22Paushak Limited to Report Q4, 2025 Results on May 01, 2025Paushak Limited announced that they will report Q4, 2025 results on May 01, 2025お知らせ • Apr 03Paushak Limited Announces Resignation of Mr. Abhijit Joshi as Chief Executive OfficerPaushak Limited announced that Mr. Abhijit Joshi (DIN: 06568584), as CEO having superannuated, resigned from the services (including directorship) of the Company, effective from 2nd April, 2025 (after close of business hours). The Board of Directors of the Company place on record their sincere appreciation for the contribution made by Mr. Abhijit Joshi during his association with the Company.お知らせ • Apr 02Paushak Limited Announces Resignation of Mr. Abhijit Joshi as Whole-Time Director, Effective 2 April 2025Paushak Limited announced that Mr. Abhijit Joshi, Whole-time Director & CEO having superannuated, resigned from the services (including directorship) of the Company, effective from 2 April 2025.Valuation Update With 7 Day Price Move • Mar 26Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹5,000, the stock trades at a trailing P/E ratio of 26.6x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 51% over the past three years.お知らせ • Mar 25Paushak Limited Announces Chief Financial Officer ChangesPaushak Limited informed that Ms. Kirti Shah, CFO has resumed office with effect from 24 March, 2025 (Key Managerial Personnel). In view of the same, Mr. Kaushik Shah, ceases to be Acting CFO (Key Managerial Personnel) of the Company with effect from 24 March, 2025.Reported Earnings • Jan 31Third quarter 2025 earnings released: EPS: ₹49.51 (vs ₹44.21 in 3Q 2024)Third quarter 2025 results: EPS: ₹49.51 (up from ₹44.21 in 3Q 2024). Revenue: ₹555.7m (up 7.3% from 3Q 2024). Net income: ₹152.6m (up 12% from 3Q 2024). Profit margin: 28% (up from 26% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings.お知らせ • Jan 22Paushak Limited to Report Q3, 2025 Results on Jan 30, 2025Paushak Limited announced that they will report Q3, 2025 results on Jan 30, 2025Reported Earnings • Oct 30Second quarter 2025 earnings released: EPS: ₹46.09 (vs ₹43.25 in 2Q 2024)Second quarter 2025 results: EPS: ₹46.09 (up from ₹43.25 in 2Q 2024). Revenue: ₹609.7m (up 17% from 2Q 2024). Net income: ₹142.0m (up 6.5% from 2Q 2024). Profit margin: 23% (down from 26% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.お知らせ • Oct 19Paushak Limited to Report Q2, 2025 Results on Oct 29, 2024Paushak Limited announced that they will report Q2, 2025 results on Oct 29, 2024お知らせ • Sep 16Paushak Limited Appoints Jain Parkash as Sr. Vice President Operations ExcellencePaushak Limited announced that Mr. Jain Parkash is appointed as Sr. Vice President Operations Excellence, designated as Senior Management Personnel, effective September 16, 2024. Mr. Jain Parkash has done Bachelor's of Engineering (B.E.) in Industrial Engineering with Honours from Thapar University, Patiala. He has about 35 years of rich experience in Specialty Chemicals, Agro-Chemicals & Pharma intermediates. He had been associated with Punjab Chemicals & Crop Protection Limited and Tagros Chemicals India Limited.Board Change • Sep 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Tushar Shah was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Aug 06+ 1 more updatePaushak Limited Announces Cessation of Atul Patel as Independent DirectorPaushak Limited announced that Mr. Atul Patel (DIN: 00009587) will be completing his second term of five consecutive years as an Independent Director and consequently shall cease to be Director of the Company with effect from 6th August, 2024 end of the day.お知らせ • Aug 03Paushak Limited Appoints Tanuj Patel as Independent DirectorPaushak Limited at its Annual General Meeting held on August 2, 2024, approved appointment of Mr. Tanuj Patel as an Independent Director of the Company.お知らせ • Jul 25Paushak Limited to Report Q1, 2025 Results on Aug 02, 2024Paushak Limited announced that they will report Q1, 2025 results on Aug 02, 2024Upcoming Dividend • Jul 19Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 26 July 2024. Payment date: 01 September 2024. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.7%).Reported Earnings • Jul 06Full year 2024 earnings released: EPS: ₹176 (vs ₹175 in FY 2023)Full year 2024 results: EPS: ₹176 (up from ₹175 in FY 2023). Revenue: ₹2.06b (down 2.9% from FY 2023). Net income: ₹543.5m (flat on FY 2023). Profit margin: 26% (up from 25% in FY 2023). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.お知らせ • Jun 18Paushak Limited, Annual General Meeting, Aug 02, 2024Paushak Limited, Annual General Meeting, Aug 02, 2024, at 17:00 Indian Standard Time.Declared Dividend • Jun 17Dividend increased to ₹20.00Dividend of ₹20.00 is 14% higher than last year. Ex-date: 26th July 2024 Payment date: 1st September 2024 Dividend yield will be 0.3%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (11% earnings payout ratio) and cash flows (36% cash payout ratio). The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 7.0% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹6,004, the stock trades at a trailing P/E ratio of 34x. Average trailing P/E is 32x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years.Reported Earnings • May 04Full year 2024 earnings released: EPS: ₹176 (vs ₹175 in FY 2023)Full year 2024 results: EPS: ₹176 (up from ₹175 in FY 2023). Revenue: ₹2.27b (up 6.8% from FY 2023). Net income: ₹543.5m (flat on FY 2023). Profit margin: 24% (down from 25% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • Apr 26Paushak Limited to Report Q4, 2024 Results on May 03, 2024Paushak Limited announced that they will report Q4, 2024 results on May 03, 2024Reported Earnings • Feb 04Third quarter 2024 earnings released: EPS: ₹44.21 (vs ₹48.73 in 3Q 2023)Third quarter 2024 results: EPS: ₹44.21 (down from ₹48.73 in 3Q 2023). Revenue: ₹548.7m (down 1.6% from 3Q 2023). Net income: ₹136.3m (down 9.3% from 3Q 2023). Profit margin: 25% (down from 27% in 3Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 25Paushak Limited to Report Q3, 2024 Results on Feb 02, 2024Paushak Limited announced that they will report Q3, 2024 results on Feb 02, 2024Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹43.25 (vs ₹42.47 in 2Q 2023)Second quarter 2024 results: EPS: ₹43.25 (up from ₹42.47 in 2Q 2023). Revenue: ₹623.0m (up 25% from 2Q 2023). Net income: ₹133.3m (up 1.8% from 2Q 2023). Profit margin: 21% (down from 26% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 19% per year whereas the company’s share price has increased by 20% per year.お知らせ • Nov 03Paushak Limited Appoints Chintan Gosaliya as Chief Operating OfficerPaushak Limited announced that Mr. Chintan Gosaliya has joined the Company as Chief Operating Officer and Senior Management Personnel w.e.f. 2nd November, 2023. Mr. Chintan Gosaliya has more than two decades of experience in the Chemicals industry. He has done B. E. Chemical from South Gujarat University & PGEPM from S. P. Jain Institute of Management and Research, Mumbai. Prior to joining the Company, he was associated with Jubilant Ingrevia Limited for about 8 years and was lastly holding the position of Sr. Vice President (Chemicals Intermediate), heading the business segment. He had also worked with Tata Chemicals Limited for about 15 years where he has performed various roles in operations and business development.お知らせ • Oct 31Paushak Limited to Report Q2, 2024 Results on Nov 08, 2023Paushak Limited announced that they will report Q2, 2024 results on Nov 08, 2023お知らせ • Aug 03Paushak Limited Approves the Appointment of Tushar Shah as Independent DirectorPaushak Limited at its AGM held on August 1, 2023, approved the appointment of Dr. Tushar Shah as an Independent Director of the company.お知らせ • Jul 25Paushak Limited to Report Q1, 2024 Results on Aug 01, 2023Paushak Limited announced that they will report Q1, 2024 results on Aug 01, 2023Upcoming Dividend • Jul 18Upcoming dividend of ₹17.50 per share at 0.3% yieldEligible shareholders must have bought the stock before 25 July 2023. Payment date: 31 August 2023. Payout ratio is a comfortable 10.0% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%).Reported Earnings • Jul 08Full year 2023 earnings released: EPS: ₹175 (vs ₹122 in FY 2022)Full year 2023 results: EPS: ₹175 (up from ₹122 in FY 2022). Revenue: ₹2.12b (up 42% from FY 2022). Net income: ₹540.1m (up 44% from FY 2022). Profit margin: 25% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jun 16Paushak Limited, Annual General Meeting, Aug 01, 2023Paushak Limited, Annual General Meeting, Aug 01, 2023, at 16:00 Indian Standard Time.Reported Earnings • May 07Full year 2023 earnings released: EPS: ₹175 (vs ₹122 in FY 2022)Full year 2023 results: EPS: ₹175 (up from ₹122 in FY 2022). Revenue: ₹2.21b (up 48% from FY 2022). Net income: ₹540.1m (up 44% from FY 2022). Profit margin: 24% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 05Paushak Limited Recommends Dividend for the Financial Year Ended 31 March 2023The board of directors of Paushak Limited meeting held on May 4, 2023, recommended dividend of INR 17.50/- (175%) per Equity Share having face value of INR 10/- each, subject To Approve the Shareholders at the upcoming Annual General Meeting ('AGM').Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹7,584, the stock trades at a trailing P/E ratio of 44.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 286% over the past three years.Reported Earnings • Jan 28Third quarter 2023 earnings released: EPS: ₹48.73 (vs ₹23.29 in 3Q 2022)Third quarter 2023 results: EPS: ₹48.73 (up from ₹23.29 in 3Q 2022). Revenue: ₹570.0m (up 68% from 3Q 2022). Net income: ₹150.2m (up 109% from 3Q 2022). Profit margin: 26% (up from 21% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 28Paushak Limited Announces Executive Changes, Effective March 31, 2023Paushak Limited announced that at the board meeting held on January 27, 2023, the company approved the resignation of Ms. Manisha Saraf (ICSI Membership No. A20998) as the Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company with effect from 31st March, 2023 (after the closure of business hours) on account of her movement within the group due to internal reorganization. Appointment of Mr. Sagar Gandhi (ICSI Membership No. A44519) as the Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company with effect from 1st April, 2023. (also on account of movement within the group due to internal re-organisation).お知らせ • Jan 19Paushak Limited to Report Q3, 2023 Results on Jan 27, 2023Paushak Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Jan 27, 2023Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 6 highly experienced directors. Non-Executive Independent Director Atul Patel was the last director to join the board, commencing their role in 2013. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 12Second quarter 2023 earnings released: EPS: ₹42.47 (vs ₹46.33 in 2Q 2022)Second quarter 2023 results: EPS: ₹42.47 (down from ₹46.33 in 2Q 2022). Revenue: ₹544.8m (up 34% from 2Q 2022). Net income: ₹130.9m (down 8.3% from 2Q 2022). Profit margin: 24% (down from 35% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 50% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Nov 03Paushak Limited to Report Q2, 2023 Results on Nov 10, 2022Paushak Limited announced that they will report Q2, 2023 results at 3:30 PM, Indian Standard Time on Nov 10, 2022Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: ₹37.47 (vs ₹9.51 in 1Q 2022)First quarter 2023 results: EPS: ₹37.47 (up from ₹9.51 in 1Q 2022). Revenue: ₹510.3m (up 123% from 1Q 2022). Net income: ₹115.5m (up 294% from 1Q 2022). Profit margin: 23% (up from 13% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • Jul 25Upcoming dividend of ₹12.00 per shareEligible shareholders must have bought the stock before 01 August 2022. Payment date: 12 August 2022. Payout ratio is a comfortable 9.8% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.7%). Lower than average of industry peers (0.8%).Reported Earnings • Jul 13Full year 2022 earnings released: EPS: ₹122 (vs ₹121 in FY 2021)Full year 2022 results: EPS: ₹122 (up from ₹121 in FY 2021). Revenue: ₹1.50b (up 6.5% from FY 2021). Net income: ₹376.1m (flat on FY 2021). Profit margin: 25% (down from 27% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 55% per year, which means it is well ahead of earnings.お知らせ • Jul 06Paushak Limited, Annual General Meeting, Aug 09, 2022Paushak Limited, Annual General Meeting, Aug 09, 2022, at 16:00 Indian Standard Time.お知らせ • Jul 02Paushak Limited Announces Resignation of Shamita Amin as Independent DirectorPaushak Limited announced that Dr. Shamita Amin, Independent Director of the Company has vide her resignation letter dated 30th June, 2022, resigned from the Directorship of the Company effective from the close of business hours on 30th June, 2022, on account of advancing age and indifferent health. Further, Dr. Shamita Amin has confirmed in the resignation letter dated 30th June, 2022 that there are no other material reasons for her resignation.Reported Earnings • May 08Full year 2022 earnings released: EPS: ₹122 (vs ₹121 in FY 2021)Full year 2022 results: EPS: ₹122 (up from ₹121 in FY 2021). Revenue: ₹1.55b (up 10% from FY 2021). Net income: ₹376.1m (flat on FY 2021). Profit margin: 24% (down from 27% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 66% per year, which means it is well ahead of earnings.お知らせ • May 08Paushak Limited Recommends Dividend for the Year Ended March 31, 2022Paushak Limited announced that at its board meeting held on May 6, 2022, recommended a dividend of INR 12 (120%) per Equity Share having face value of INR 10 each for the year ended March 31, 2022, subject To Approve the Shareholders at the upcoming Annual General Meeting.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 6 highly experienced directors. Non-Executive Independent Director Shamita Amin was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 03Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹23.29 (down from ₹37.44 in 3Q 2021). Revenue: ₹344.1m (down 15% from 3Q 2021). Net income: ₹71.8m (down 38% from 3Q 2021). Profit margin: 21% (down from 29% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 78% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹9,770, the stock trades at a trailing P/E ratio of 75.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 304% over the past three years.Reported Earnings • Nov 03Second quarter 2022 earnings released: EPS ₹46.33 (vs ₹19.84 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹406.3m (up 37% from 2Q 2021). Net income: ₹142.8m (up 134% from 2Q 2021). Profit margin: 35% (up from 21% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 71% per year, which means it is well ahead of earnings.Board Change • Sep 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 4 highly experienced directors. Non-Executive Independent Director Shamita Amin was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.お知らせ • Jun 02Paushak Limited Announces Temporary Suspension of Manufacturing OperationsPaushak Limited informing about the temporary suspension of company manufacturing operations due to restriction in supply of oxygen for industrial purposes. Company informed that the company has resumed its manufacturing operations as supply of industrial oxygen has been re-stored by the supplier, upon receipt of requisite approvals for the purpose.お知らせ • May 12Paushak Limited Recommends DividendPaushak Limited announced that at the board meeting held on May 10, 2021, the company recommended a dividend of INR 6.00/- (60%) per Equity Share having face value of INR 10/- each, subject To Approve the Shareholders at the upcoming Annual General Meeting.Reported Earnings • May 11Full year 2021 earnings released: EPS ₹121 (vs ₹113 in FY 2020)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2021 results: Revenue: ₹1.47b (up 6.7% from FY 2020). Net income: ₹373.0m (up 6.8% from FY 2020). Profit margin: 25% (in line with FY 2020). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth.Executive Departure • May 01CEO & Whole-Time Director Abhijit Joshi has left the companyOn the 30th of April, Abhijit Joshi's tenure as CEO & Whole-Time Director of the company ended. We don't have any record of a personal shareholding under Abhijit's name. A total of 2 executives have left over the last 12 months.Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 39% share price gain to ₹7,334, the stock is trading at a trailing P/E ratio of 69.2x, up from the previous P/E ratio of 49.9x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 417%.Is New 90 Day High Low • Feb 25New 90-day high: ₹5,877The company is up 72% from its price of ₹3,425 on 27 November 2020. The Indian market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹4,889, the stock is trading at a trailing P/E ratio of 46.1x, up from the previous P/E ratio of 38.2x. This compares to an average P/E of 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 222%.Is New 90 Day High Low • Feb 09New 90-day high: ₹4,301The company is up 28% from its price of ₹3,365 on 11 November 2020. The Indian market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.Reported Earnings • Jan 30Third quarter 2021 earnings released: EPS ₹37.44 (vs ₹35.75 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: ₹432.4m (up 13% from 3Q 2020). Net income: ₹115.4m (up 4.8% from 3Q 2020). Profit margin: 27% (down from 29% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 21Paushak Limited to Report Q3, 2021 Results on Jan 29, 2021Paushak Limited announced that they will report Q3, 2021 results on Jan 29, 2021Is New 90 Day High Low • Jan 16New 90-day high: ₹3,997The company is up 8.0% from its price of ₹3,694 on 16 October 2020. The Indian market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.Is New 90 Day High Low • Nov 01New 90-day low: ₹3,554The company is down 4.0% from its price of ₹3,700 on 03 August 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.Reported Earnings • Oct 28First half earnings releasedOver the last 12 months the company has reported total profits of ₹321.4m, down 6.7% from the prior year. Total revenue was ₹1.30b over the last 12 months, down 12% from the prior year.お知らせ • Sep 12Paushak Limited to Report Q1, 2021 Results on Aug 04, 2020Paushak Limited announced that they will report Q1, 2021 results on Aug 04, 2020 このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Paushak は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測BSE:532742 - アナリストの将来予測と過去の財務データ ( )INR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20262,186393-344537N/A12/31/20252,158364N/AN/AN/A9/30/20252,163455-1,249370N/A6/30/20252,148511N/AN/AN/A3/31/20252,109494-1,229376N/A12/31/20242,124580N/AN/AN/A9/30/20242,150564-339489N/A6/30/20242,097555N/AN/AN/A3/31/20242,063544170560N/A12/31/20232,089504N/AN/AN/A9/30/20232,128518305586N/A6/30/20232,107516N/AN/AN/A3/31/20232,123540256427N/A12/31/20222,085529N/AN/AN/A9/30/20221,868450220418N/A6/30/20221,776462N/AN/AN/A3/31/20221,501376-43440N/A12/31/20211,362354N/AN/AN/A9/30/20211,426398-452317N/A6/30/20211,316316N/AN/AN/A3/31/20211,410373-260298N/A12/31/20201,315327N/AN/AN/A9/30/20201,295321160431N/A6/30/20201,343335N/AN/AN/A3/31/20201,379349242454N/A12/31/20191,473382N/AN/AN/A9/30/20191,471344N/A255N/A6/30/20191,456347N/AN/AN/A3/31/20191,396390N/A235N/A12/31/20181,375371N/AN/AN/A9/30/20181,285348N/AN/AN/A6/30/20181,158319N/AN/AN/A3/31/20181,036215N/A105N/A12/31/2017784184N/AN/AN/A9/30/2017691160N/AN/AN/A6/30/2017732131N/AN/AN/A3/31/2017669109N/A124N/A12/31/201668380N/AN/AN/A9/30/201666975N/AN/AN/A6/30/201671399N/AN/AN/A3/31/2016779124N/A135N/A12/31/2015823145N/AN/AN/A9/30/2015833154N/AN/AN/A6/30/2015775156N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 532742の予測収益成長が 貯蓄率 ( 6.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 532742の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 532742の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 532742の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 532742の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 532742の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/12 01:32終値2026/06/12 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Paushak Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Anil BurraFirstCall Research
お知らせ • Jun 02Paushak Limited Announces Temporary Suspension of Manufacturing OperationsPaushak Limited informing about the temporary suspension of company manufacturing operations due to restriction in supply of oxygen for industrial purposes. Company informed that the company has resumed its manufacturing operations as supply of industrial oxygen has been re-stored by the supplier, upon receipt of requisite approvals for the purpose.
お知らせ • 7hPaushak Limited, Annual General Meeting, Jul 30, 2026Paushak Limited, Annual General Meeting, Jul 30, 2026, at 17:00 Indian Standard Time.
お知らせ • Apr 28Paushak Limited to Report Q4, 2026 Results on May 05, 2026Paushak Limited announced that they will report Q4, 2026 results on May 05, 2026
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹423, the stock trades at a trailing P/E ratio of 28.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 54% over the past three years.
New Risk • Mar 23New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹9.20b (US$98.4m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (17% net profit margin). Market cap is less than US$100m (₹9.20b market cap, or US$98.4m).
New Risk • Jan 28New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 18% Last year net profit margin: 27% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.2% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (18% net profit margin).
お知らせ • Jan 19Paushak Limited to Report Q3, 2026 Results on Jan 27, 2026Paushak Limited announced that they will report Q3, 2026 results on Jan 27, 2026
Valuation Update With 7 Day Price Move • Nov 14Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to ₹597, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 44% over the past three years.
Reported Earnings • Nov 08Second quarter 2026 earnings released: EPS: ₹27.94 (vs ₹5.76 in 2Q 2025)Second quarter 2026 results: EPS: ₹27.94. Revenue: ₹598.3m (up 4.4% from 2Q 2025). Net income: ₹86.1m (down 39% from 2Q 2025). Profit margin: 14% (down from 25% in 2Q 2025). The decrease in margin was driven by higher expenses.
お知らせ • Oct 31Paushak Limited to Report Q2, 2026 Results on Nov 07, 2025Paushak Limited announced that they will report Q2, 2026 results on Nov 07, 2025
Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹960, the stock trades at a trailing P/E ratio of 46.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 13% over the past three years.
New Risk • Oct 03New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 25% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (25% average weekly change). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₹2.96b market cap, or US$33.3m).
Reported Earnings • Aug 01First quarter 2026 earnings released: EPS: ₹39.04 (vs ₹33.44 in 1Q 2025)First quarter 2026 results: EPS: ₹39.04 (up from ₹33.44 in 1Q 2025). Revenue: ₹577.7m (up 11% from 1Q 2025). Net income: ₹120.3m (up 17% from 1Q 2025). Profit margin: 21% (in line with 1Q 2025). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.
お知らせ • Jul 23Paushak Limited to Report Q1, 2026 Results on Jul 31, 2025Paushak Limited announced that they will report Q1, 2026 results on Jul 31, 2025
Upcoming Dividend • Jul 17Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 24 July 2025. Payment date: 30 August 2025. Payout ratio is a comfortable 12% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.7%).
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹5,656, the stock trades at a trailing P/E ratio of 35.3x. Average trailing P/E is 29x in the Chemicals industry in India. Total loss to shareholders of 39% over the past three years.
Reported Earnings • Jul 03Full year 2025 earnings released: EPS: ₹160 (vs ₹176 in FY 2024)Full year 2025 results: EPS: ₹160 (down from ₹176 in FY 2024). Revenue: ₹2.11b (up 2.3% from FY 2024). Net income: ₹493.8m (down 9.2% from FY 2024). Profit margin: 23% (down from 26% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.
Declared Dividend • Jun 30Dividend of ₹20.00 announcedDividend of ₹20.00 is the same as last year. Ex-date: 24th July 2025 Payment date: 30th August 2025 Dividend yield will be 0.4%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (12% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 7.2% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 30Paushak Limited, Annual General Meeting, Jul 31, 2025Paushak Limited, Annual General Meeting, Jul 31, 2025, at 17:00 Indian Standard Time.
Reported Earnings • May 03Full year 2025 earnings released: EPS: ₹160 (vs ₹176 in FY 2024)Full year 2025 results: EPS: ₹160 (down from ₹176 in FY 2024). Revenue: ₹2.25b (up 9.2% from FY 2024). Net income: ₹493.8m (down 9.1% from FY 2024). Profit margin: 22% (down from 26% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings.
お知らせ • May 01Paushak Limited Recommends Dividend for the Year Ended March 31, 2025Paushak Limited at its board meeting held on May 1, 2025, recommended a dividend of INR 20 (200%) per Equity Share having face value of INR 10 each for the year ended March 31, 2025, subject To Approve the Shareholders at the upcoming Annual General Meeting (AGM).
お知らせ • Apr 22Paushak Limited to Report Q4, 2025 Results on May 01, 2025Paushak Limited announced that they will report Q4, 2025 results on May 01, 2025
お知らせ • Apr 03Paushak Limited Announces Resignation of Mr. Abhijit Joshi as Chief Executive OfficerPaushak Limited announced that Mr. Abhijit Joshi (DIN: 06568584), as CEO having superannuated, resigned from the services (including directorship) of the Company, effective from 2nd April, 2025 (after close of business hours). The Board of Directors of the Company place on record their sincere appreciation for the contribution made by Mr. Abhijit Joshi during his association with the Company.
お知らせ • Apr 02Paushak Limited Announces Resignation of Mr. Abhijit Joshi as Whole-Time Director, Effective 2 April 2025Paushak Limited announced that Mr. Abhijit Joshi, Whole-time Director & CEO having superannuated, resigned from the services (including directorship) of the Company, effective from 2 April 2025.
Valuation Update With 7 Day Price Move • Mar 26Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹5,000, the stock trades at a trailing P/E ratio of 26.6x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 51% over the past three years.
お知らせ • Mar 25Paushak Limited Announces Chief Financial Officer ChangesPaushak Limited informed that Ms. Kirti Shah, CFO has resumed office with effect from 24 March, 2025 (Key Managerial Personnel). In view of the same, Mr. Kaushik Shah, ceases to be Acting CFO (Key Managerial Personnel) of the Company with effect from 24 March, 2025.
Reported Earnings • Jan 31Third quarter 2025 earnings released: EPS: ₹49.51 (vs ₹44.21 in 3Q 2024)Third quarter 2025 results: EPS: ₹49.51 (up from ₹44.21 in 3Q 2024). Revenue: ₹555.7m (up 7.3% from 3Q 2024). Net income: ₹152.6m (up 12% from 3Q 2024). Profit margin: 28% (up from 26% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings.
お知らせ • Jan 22Paushak Limited to Report Q3, 2025 Results on Jan 30, 2025Paushak Limited announced that they will report Q3, 2025 results on Jan 30, 2025
Reported Earnings • Oct 30Second quarter 2025 earnings released: EPS: ₹46.09 (vs ₹43.25 in 2Q 2024)Second quarter 2025 results: EPS: ₹46.09 (up from ₹43.25 in 2Q 2024). Revenue: ₹609.7m (up 17% from 2Q 2024). Net income: ₹142.0m (up 6.5% from 2Q 2024). Profit margin: 23% (down from 26% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings.
お知らせ • Oct 19Paushak Limited to Report Q2, 2025 Results on Oct 29, 2024Paushak Limited announced that they will report Q2, 2025 results on Oct 29, 2024
お知らせ • Sep 16Paushak Limited Appoints Jain Parkash as Sr. Vice President Operations ExcellencePaushak Limited announced that Mr. Jain Parkash is appointed as Sr. Vice President Operations Excellence, designated as Senior Management Personnel, effective September 16, 2024. Mr. Jain Parkash has done Bachelor's of Engineering (B.E.) in Industrial Engineering with Honours from Thapar University, Patiala. He has about 35 years of rich experience in Specialty Chemicals, Agro-Chemicals & Pharma intermediates. He had been associated with Punjab Chemicals & Crop Protection Limited and Tagros Chemicals India Limited.
Board Change • Sep 11Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Tushar Shah was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Aug 06+ 1 more updatePaushak Limited Announces Cessation of Atul Patel as Independent DirectorPaushak Limited announced that Mr. Atul Patel (DIN: 00009587) will be completing his second term of five consecutive years as an Independent Director and consequently shall cease to be Director of the Company with effect from 6th August, 2024 end of the day.
お知らせ • Aug 03Paushak Limited Appoints Tanuj Patel as Independent DirectorPaushak Limited at its Annual General Meeting held on August 2, 2024, approved appointment of Mr. Tanuj Patel as an Independent Director of the Company.
お知らせ • Jul 25Paushak Limited to Report Q1, 2025 Results on Aug 02, 2024Paushak Limited announced that they will report Q1, 2025 results on Aug 02, 2024
Upcoming Dividend • Jul 19Upcoming dividend of ₹20.00 per shareEligible shareholders must have bought the stock before 26 July 2024. Payment date: 01 September 2024. Payout ratio is a comfortable 11% and this is well supported by cash flows. Trailing yield: 0.4%. Lower than top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (0.7%).
Reported Earnings • Jul 06Full year 2024 earnings released: EPS: ₹176 (vs ₹175 in FY 2023)Full year 2024 results: EPS: ₹176 (up from ₹175 in FY 2023). Revenue: ₹2.06b (down 2.9% from FY 2023). Net income: ₹543.5m (flat on FY 2023). Profit margin: 26% (up from 25% in FY 2023). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
お知らせ • Jun 18Paushak Limited, Annual General Meeting, Aug 02, 2024Paushak Limited, Annual General Meeting, Aug 02, 2024, at 17:00 Indian Standard Time.
Declared Dividend • Jun 17Dividend increased to ₹20.00Dividend of ₹20.00 is 14% higher than last year. Ex-date: 26th July 2024 Payment date: 1st September 2024 Dividend yield will be 0.3%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (11% earnings payout ratio) and cash flows (36% cash payout ratio). The dividend has increased by an average of 21% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 7.0% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹6,004, the stock trades at a trailing P/E ratio of 34x. Average trailing P/E is 32x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years.
Reported Earnings • May 04Full year 2024 earnings released: EPS: ₹176 (vs ₹175 in FY 2023)Full year 2024 results: EPS: ₹176 (up from ₹175 in FY 2023). Revenue: ₹2.27b (up 6.8% from FY 2023). Net income: ₹543.5m (flat on FY 2023). Profit margin: 24% (down from 25% in FY 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • Apr 26Paushak Limited to Report Q4, 2024 Results on May 03, 2024Paushak Limited announced that they will report Q4, 2024 results on May 03, 2024
Reported Earnings • Feb 04Third quarter 2024 earnings released: EPS: ₹44.21 (vs ₹48.73 in 3Q 2023)Third quarter 2024 results: EPS: ₹44.21 (down from ₹48.73 in 3Q 2023). Revenue: ₹548.7m (down 1.6% from 3Q 2023). Net income: ₹136.3m (down 9.3% from 3Q 2023). Profit margin: 25% (down from 27% in 3Q 2023). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 25Paushak Limited to Report Q3, 2024 Results on Feb 02, 2024Paushak Limited announced that they will report Q3, 2024 results on Feb 02, 2024
Reported Earnings • Nov 09Second quarter 2024 earnings released: EPS: ₹43.25 (vs ₹42.47 in 2Q 2023)Second quarter 2024 results: EPS: ₹43.25 (up from ₹42.47 in 2Q 2023). Revenue: ₹623.0m (up 25% from 2Q 2023). Net income: ₹133.3m (up 1.8% from 2Q 2023). Profit margin: 21% (down from 26% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 19% per year whereas the company’s share price has increased by 20% per year.
お知らせ • Nov 03Paushak Limited Appoints Chintan Gosaliya as Chief Operating OfficerPaushak Limited announced that Mr. Chintan Gosaliya has joined the Company as Chief Operating Officer and Senior Management Personnel w.e.f. 2nd November, 2023. Mr. Chintan Gosaliya has more than two decades of experience in the Chemicals industry. He has done B. E. Chemical from South Gujarat University & PGEPM from S. P. Jain Institute of Management and Research, Mumbai. Prior to joining the Company, he was associated with Jubilant Ingrevia Limited for about 8 years and was lastly holding the position of Sr. Vice President (Chemicals Intermediate), heading the business segment. He had also worked with Tata Chemicals Limited for about 15 years where he has performed various roles in operations and business development.
お知らせ • Oct 31Paushak Limited to Report Q2, 2024 Results on Nov 08, 2023Paushak Limited announced that they will report Q2, 2024 results on Nov 08, 2023
お知らせ • Aug 03Paushak Limited Approves the Appointment of Tushar Shah as Independent DirectorPaushak Limited at its AGM held on August 1, 2023, approved the appointment of Dr. Tushar Shah as an Independent Director of the company.
お知らせ • Jul 25Paushak Limited to Report Q1, 2024 Results on Aug 01, 2023Paushak Limited announced that they will report Q1, 2024 results on Aug 01, 2023
Upcoming Dividend • Jul 18Upcoming dividend of ₹17.50 per share at 0.3% yieldEligible shareholders must have bought the stock before 25 July 2023. Payment date: 31 August 2023. Payout ratio is a comfortable 10.0% and this is well supported by cash flows. Trailing yield: 0.3%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%).
Reported Earnings • Jul 08Full year 2023 earnings released: EPS: ₹175 (vs ₹122 in FY 2022)Full year 2023 results: EPS: ₹175 (up from ₹122 in FY 2022). Revenue: ₹2.12b (up 42% from FY 2022). Net income: ₹540.1m (up 44% from FY 2022). Profit margin: 25% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jun 16Paushak Limited, Annual General Meeting, Aug 01, 2023Paushak Limited, Annual General Meeting, Aug 01, 2023, at 16:00 Indian Standard Time.
Reported Earnings • May 07Full year 2023 earnings released: EPS: ₹175 (vs ₹122 in FY 2022)Full year 2023 results: EPS: ₹175 (up from ₹122 in FY 2022). Revenue: ₹2.21b (up 48% from FY 2022). Net income: ₹540.1m (up 44% from FY 2022). Profit margin: 24% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 05Paushak Limited Recommends Dividend for the Financial Year Ended 31 March 2023The board of directors of Paushak Limited meeting held on May 4, 2023, recommended dividend of INR 17.50/- (175%) per Equity Share having face value of INR 10/- each, subject To Approve the Shareholders at the upcoming Annual General Meeting ('AGM').
Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹7,584, the stock trades at a trailing P/E ratio of 44.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 286% over the past three years.
Reported Earnings • Jan 28Third quarter 2023 earnings released: EPS: ₹48.73 (vs ₹23.29 in 3Q 2022)Third quarter 2023 results: EPS: ₹48.73 (up from ₹23.29 in 3Q 2022). Revenue: ₹570.0m (up 68% from 3Q 2022). Net income: ₹150.2m (up 109% from 3Q 2022). Profit margin: 26% (up from 21% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 28Paushak Limited Announces Executive Changes, Effective March 31, 2023Paushak Limited announced that at the board meeting held on January 27, 2023, the company approved the resignation of Ms. Manisha Saraf (ICSI Membership No. A20998) as the Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company with effect from 31st March, 2023 (after the closure of business hours) on account of her movement within the group due to internal reorganization. Appointment of Mr. Sagar Gandhi (ICSI Membership No. A44519) as the Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company with effect from 1st April, 2023. (also on account of movement within the group due to internal re-organisation).
お知らせ • Jan 19Paushak Limited to Report Q3, 2023 Results on Jan 27, 2023Paushak Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Jan 27, 2023
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 6 highly experienced directors. Non-Executive Independent Director Atul Patel was the last director to join the board, commencing their role in 2013. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 12Second quarter 2023 earnings released: EPS: ₹42.47 (vs ₹46.33 in 2Q 2022)Second quarter 2023 results: EPS: ₹42.47 (down from ₹46.33 in 2Q 2022). Revenue: ₹544.8m (up 34% from 2Q 2022). Net income: ₹130.9m (down 8.3% from 2Q 2022). Profit margin: 24% (down from 35% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 50% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Nov 03Paushak Limited to Report Q2, 2023 Results on Nov 10, 2022Paushak Limited announced that they will report Q2, 2023 results at 3:30 PM, Indian Standard Time on Nov 10, 2022
Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: ₹37.47 (vs ₹9.51 in 1Q 2022)First quarter 2023 results: EPS: ₹37.47 (up from ₹9.51 in 1Q 2022). Revenue: ₹510.3m (up 123% from 1Q 2022). Net income: ₹115.5m (up 294% from 1Q 2022). Profit margin: 23% (up from 13% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • Jul 25Upcoming dividend of ₹12.00 per shareEligible shareholders must have bought the stock before 01 August 2022. Payment date: 12 August 2022. Payout ratio is a comfortable 9.8% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of Indian dividend payers (1.7%). Lower than average of industry peers (0.8%).
Reported Earnings • Jul 13Full year 2022 earnings released: EPS: ₹122 (vs ₹121 in FY 2021)Full year 2022 results: EPS: ₹122 (up from ₹121 in FY 2021). Revenue: ₹1.50b (up 6.5% from FY 2021). Net income: ₹376.1m (flat on FY 2021). Profit margin: 25% (down from 27% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 55% per year, which means it is well ahead of earnings.
お知らせ • Jul 06Paushak Limited, Annual General Meeting, Aug 09, 2022Paushak Limited, Annual General Meeting, Aug 09, 2022, at 16:00 Indian Standard Time.
お知らせ • Jul 02Paushak Limited Announces Resignation of Shamita Amin as Independent DirectorPaushak Limited announced that Dr. Shamita Amin, Independent Director of the Company has vide her resignation letter dated 30th June, 2022, resigned from the Directorship of the Company effective from the close of business hours on 30th June, 2022, on account of advancing age and indifferent health. Further, Dr. Shamita Amin has confirmed in the resignation letter dated 30th June, 2022 that there are no other material reasons for her resignation.
Reported Earnings • May 08Full year 2022 earnings released: EPS: ₹122 (vs ₹121 in FY 2021)Full year 2022 results: EPS: ₹122 (up from ₹121 in FY 2021). Revenue: ₹1.55b (up 10% from FY 2021). Net income: ₹376.1m (flat on FY 2021). Profit margin: 24% (down from 27% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 66% per year, which means it is well ahead of earnings.
お知らせ • May 08Paushak Limited Recommends Dividend for the Year Ended March 31, 2022Paushak Limited announced that at its board meeting held on May 6, 2022, recommended a dividend of INR 12 (120%) per Equity Share having face value of INR 10 each for the year ended March 31, 2022, subject To Approve the Shareholders at the upcoming Annual General Meeting.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 6 highly experienced directors. Non-Executive Independent Director Shamita Amin was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 03Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹23.29 (down from ₹37.44 in 3Q 2021). Revenue: ₹344.1m (down 15% from 3Q 2021). Net income: ₹71.8m (down 38% from 3Q 2021). Profit margin: 21% (down from 29% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 78% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹9,770, the stock trades at a trailing P/E ratio of 75.7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 304% over the past three years.
Reported Earnings • Nov 03Second quarter 2022 earnings released: EPS ₹46.33 (vs ₹19.84 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹406.3m (up 37% from 2Q 2021). Net income: ₹142.8m (up 134% from 2Q 2021). Profit margin: 35% (up from 21% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 71% per year, which means it is well ahead of earnings.
Board Change • Sep 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 4 highly experienced directors. Non-Executive Independent Director Shamita Amin was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
お知らせ • Jun 02Paushak Limited Announces Temporary Suspension of Manufacturing OperationsPaushak Limited informing about the temporary suspension of company manufacturing operations due to restriction in supply of oxygen for industrial purposes. Company informed that the company has resumed its manufacturing operations as supply of industrial oxygen has been re-stored by the supplier, upon receipt of requisite approvals for the purpose.
お知らせ • May 12Paushak Limited Recommends DividendPaushak Limited announced that at the board meeting held on May 10, 2021, the company recommended a dividend of INR 6.00/- (60%) per Equity Share having face value of INR 10/- each, subject To Approve the Shareholders at the upcoming Annual General Meeting.
Reported Earnings • May 11Full year 2021 earnings released: EPS ₹121 (vs ₹113 in FY 2020)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2021 results: Revenue: ₹1.47b (up 6.7% from FY 2020). Net income: ₹373.0m (up 6.8% from FY 2020). Profit margin: 25% (in line with FY 2020). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 67% per year, which means it is tracking significantly ahead of earnings growth.
Executive Departure • May 01CEO & Whole-Time Director Abhijit Joshi has left the companyOn the 30th of April, Abhijit Joshi's tenure as CEO & Whole-Time Director of the company ended. We don't have any record of a personal shareholding under Abhijit's name. A total of 2 executives have left over the last 12 months.
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 39% share price gain to ₹7,334, the stock is trading at a trailing P/E ratio of 69.2x, up from the previous P/E ratio of 49.9x. This compares to an average P/E of 16x in the Chemicals industry in India. Total returns to shareholders over the past three years are 417%.
Is New 90 Day High Low • Feb 25New 90-day high: ₹5,877The company is up 72% from its price of ₹3,425 on 27 November 2020. The Indian market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
Valuation Update With 7 Day Price Move • Feb 11Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹4,889, the stock is trading at a trailing P/E ratio of 46.1x, up from the previous P/E ratio of 38.2x. This compares to an average P/E of 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 222%.
Is New 90 Day High Low • Feb 09New 90-day high: ₹4,301The company is up 28% from its price of ₹3,365 on 11 November 2020. The Indian market is up 22% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period.
Reported Earnings • Jan 30Third quarter 2021 earnings released: EPS ₹37.44 (vs ₹35.75 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: ₹432.4m (up 13% from 3Q 2020). Net income: ₹115.4m (up 4.8% from 3Q 2020). Profit margin: 27% (down from 29% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 21Paushak Limited to Report Q3, 2021 Results on Jan 29, 2021Paushak Limited announced that they will report Q3, 2021 results on Jan 29, 2021
Is New 90 Day High Low • Jan 16New 90-day high: ₹3,997The company is up 8.0% from its price of ₹3,694 on 16 October 2020. The Indian market is up 24% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.
Is New 90 Day High Low • Nov 01New 90-day low: ₹3,554The company is down 4.0% from its price of ₹3,700 on 03 August 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period.
Reported Earnings • Oct 28First half earnings releasedOver the last 12 months the company has reported total profits of ₹321.4m, down 6.7% from the prior year. Total revenue was ₹1.30b over the last 12 months, down 12% from the prior year.
お知らせ • Sep 12Paushak Limited to Report Q1, 2021 Results on Aug 04, 2020Paushak Limited announced that they will report Q1, 2021 results on Aug 04, 2020